Mechanisms of target organ damage caused by hypertension: Therapeutic potential

被引:122
作者
Cohuet, G. [1 ]
Struijker-Boudier, H. [1 ]
机构
[1] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
关键词
hypertension; target organ damage; microcirculation; therapy ronasdsd;
D O I
10.1016/j.pharmthera.2005.09.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypertension is a major risk factor for cardiovascular mortality and morbidity through its effects on target organs like the brain, heart, and kidney. Structural alterations in the microcirculation form a major link between hypertension and target organ damage. In this review, we describe damages related to hypertension in these target organs and the mechanisms involved in the pathogenesis of hypertension-induced cardiovascular diseases such as dementia, cardiac ischemia and remodeling, or nephropathy. We also focus on the therapeutical potential on the basis of such mechanisms. Several antihypertensive agents like diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin II (Ang II) receptor antagonists, beta-blockers, or calcium channel blockers (CCBs) have been shown to reduce effectively hypertension associated cardiovascular events and to improve end organ damage. More recently, aldosterone antagonism has also shown beneficial effects. Part of the favorable effects of these agents is due to blood pressure lowering as such. Other mechanisms such as oxidative stress, inflammation, or endothelial dysfunction have appeared to play a key role in the pathogenesis of target organ damage and therefore represent another important pathway for therapy. In this review, we discuss the different therapeutic approaches aiming at reducing cardiovascular events and damages induced by hypertension. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 98
页数:18
相关论文
共 240 条
  • [1] Nephrotoxicity of increased glomerular protein traffic
    Abbate, M
    Benigni, A
    Bertani, T
    Remuzzi, G
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (02) : 304 - 312
  • [2] Abbate M, 1999, J AM SOC NEPHROL, V10, P804
  • [3] Cardiac structural and functional changes during long-term anti hypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA)
    Agabiti-Rosei, E
    Trimarco, B
    Muiesan, ML
    Reid, J
    Salvetti, A
    Tang, R
    Hennig, M
    Baurecht, H
    Parati, G
    Mancia, G
    Zanchetti, A
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 (05) : 1091 - 1098
  • [4] THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION
    AMBROSIONI, E
    BORGHI, C
    MAGNANI, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02) : 80 - 85
  • [5] THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT
    ANDERSON, S
    RENNKE, HG
    BRENNER, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) : 1993 - 2000
  • [6] CONTROL OF GLOMERULAR HYPERTENSION LIMITS GLOMERULAR INJURY IN RATS WITH REDUCED RENAL MASS
    ANDERSON, S
    MEYER, TW
    RENNKE, HG
    BRENNER, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (02) : 612 - 619
  • [7] Bleeding risks, risk factors and management of bleeding complications after treatment with anticoagulants, specific antithrombins, thrombolytics IIb-IIIa receptor blockers
    Armstrong, PW
    Mant, MJ
    [J]. EUROPEAN HEART JOURNAL, 1995, 16 : 75 - 80
  • [8] An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness
    Asif, M
    Egan, J
    Vasan, S
    Jyothirmayi, GN
    Masurekar, MR
    Lopez, S
    Williams, C
    Torres, RL
    Wagle, D
    Ulrich, P
    Cerami, A
    Brines, M
    Regan, TJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2809 - 2813
  • [9] COMPARISON OF EFFECTS OF FELODIPINE VERSUS HYDROCHLOROTHIAZIDE ON ARTERIAL DIAMETER AND PULSE-WAVE VELOCITY IN ESSENTIAL-HYPERTENSION
    ASMAR, RG
    BENETOS, A
    CHAOUCHETEYARA, K
    RAVEAULANDON, CM
    SAFAR, ME
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (11) : 794 - 798
  • [10] A VASCULAR PERMEABILITY FACTOR OF RENAL ORIGIN
    ASSCHER, AW
    ANSON, SG
    [J]. NATURE, 1963, 198 (488) : 1097 - &